Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn’s disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. It is a fragment of a monoclonal antibody specific to tumor necrosis factor alpha (TNF-\u03b1) and is manufactured by UCB.<\/p>\n
If CIMZIA (certolizumab pegol) injection<\/strong> are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n Note:<\/strong> NEWS \/ UPDATES<\/strong><\/p>\n CIMZIA is a tumor necrosis factor (TNF) blocker indicated for (1) Reducing signs and symptoms of Crohn\u2019s disease and maintaining clinical (2) response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy (3) Treatment of adults with moderately to severely active rheumatoid arthritis (4) Treatment of adult patients with active psoriatic arthritis. (5) Treatment of adults with active ankylosing spondylitis.<\/p>\n Source Details:\u00a0Patient Information<\/strong><\/a><\/p>\n If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import CIMZIA (certolizumab pegol) injection\u201d <\/strong> based on the information you provide.<\/p>\n
\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.<\/p>\n\n
CIMZIA (certolizumab pegol) injection<\/h2>\n
\n\n
\n Brand Name:<\/strong><\/td>\n CIMZIA<\/td>\n<\/tr>\n \n Generic Name:<\/strong><\/td>\n certolizumab pegol<\/td>\n<\/tr>\n \n Strength:<\/strong><\/td>\n \u2022 For injection: 200 mg lyophilized powder for reconstitution in a single use vial, with 1 mL of sterile Water for Injection
\n\u2022 Injection: 200 mg\/mL solution in a single-use prefilled syringe<\/td>\n<\/tr>\n\n Manufacturer:<\/strong><\/td>\n UCB, Inc<\/td>\n<\/tr>\n \n Approved By:<\/strong><\/td>\n EMA, USFDA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n Access the best support services globally<\/h4>\n